ClinVar Miner

Submissions for variant NM_000492.3(CFTR):c.489+2T>C (rs397508732)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000577437 SCV000790974 likely pathogenic Cystic fibrosis 2017-04-18 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000781276 SCV000919189 likely pathogenic not specified 2017-11-22 criteria provided, single submitter clinical testing Variant summary: The CFTR c.489+2T>C variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict the weakening or complete loss of a cannonical splice donor site. However, these predictions have yet to be confirmed by functional studies. This variant is absent in 240558 control chromosomes. The variant has been reported in one affected patient in the homozygous state (Malone_1998). Taken together, this variant is classified as likely pathogenic.
CFTR-France RCV000577437 SCV001169314 pathogenic Cystic fibrosis 2018-01-29 criteria provided, single submitter curation
ClinVar Staff, National Center for Biotechnology Information (NCBI) RCV000577437 SCV000679160 not provided Cystic fibrosis no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.